CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus
Sang Ah Lee, Gwanpyo Koh, Suk Ju Cho, So-Yeon Yoo, Sang Ouk Chin
Endocrinol Metab. 2016;31(3):439-445.   Published online September 26, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.3.439

Excel Download

Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus
Endocrinology and Metabolism. 2016;31(3):439   Crossref logo
Link1 Link2 Link3

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
Diabetes mellitus. 2018;21(4):293-300   Crossref logo
Link1 Link2

Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2012;165   Crossref logo
Link1

The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
Diabetes mellitus. 2010;13(3):106-109   Crossref logo
Link1 Link2

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
Diabetes mellitus. 2017;20(4):286-298   Crossref logo
Link1 Link2

Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus: Results over 52 weeks
Journal of Diabetes and its Complications. 2017;31(8):1283-1285   Crossref logo
Link1 Link2

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
The Journal of Korean Diabetes. 2018;19(1):35   Crossref logo
Link1 Link2 Link3

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of double-blind, randomized, placebo-controlled clinical trials
. 2019;   Crossref logo
Link1 Link2

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of double-blind, randomized, placebo-controlled clinical trials
. 2020;   Crossref logo
Link1 Link2

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of double-blind, randomized, placebo-controlled clinical trials
. 2019;   Crossref logo
Link1 Link2